MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
  • Gait cycle-related neural activity during cued and uncued gait in Parkinson’s disease patients

    F. Gennaro, I. Talu, K. Cross (Padova, Italy)

  • Gait during turning associates with imbalance and falls in PD: 3D Video based analysis from a single camera

    JH. Shin, HY. Jeon, B. Jin, SM. Lee, KA. Woo, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

  • GBA haplotypes and age at onset of Parkinson’s disease in the Asian population

    C. Li, R. Ou, Y. Hou, Q. Wei, L. Zhang, K. Liu, J. Lin, X. Chen, W. Song, B. Zhao, Y. Wu, H. Shang (Chengdu, China)

  • GBA p.K198E mutation causing Parkinson Disease in Colombian population: the first clinical description

    L. Quintero-Giraldo, C. Moreno-López, C. Cerquera-Cleves (Bogota, Colombia)

  • Gemini digital twins identified neuro-common and disease-specific drivers of rate of change in NfL in Huntington’s disease, Parkinson disease and Alzheimer disease

    X. Shen, S. Sathe, L. Sun, P. Ashrap, K. Johnson, S. Sukhram, S. Reddy, S. Shin, J. Latourelle, C. Sampaio (Somerville, USA)

  • Gender differences in non-motor fluctuations in Parkinson’s disease

    G. Donzuso, C. Cicero, E. Vinciguerra, R. Sergi, A. Luca, G. Mostile, C. Terravecchia, M. Zappia, A. Nicoletti (Catania, Italy)

  • Gender differences in REM Sleep Behavior Disorder in Parkinson’s disease

    EL. Ungureanu, ș. Diaconu, A. Zârnoveanu, R. Filip, M. Cușnir, B. Ciopleiaș, C. Falup-Pecurariu (Brasov, Romania)

  • gender differences of fatigue and sleep characteristics in parkinson’s disease patients

    S. Diaconu, S. Berzunteanu, E. Ungureanu, B. Ciopleias, R. Zosin, M. Cusnir, A. Iacob, I. Murasan, B. Ciocanescu, C. Falup-Pecurariu (Brasov, Romania)

  • Gender inequities in people living with PD and their caregivers’ burden in Mexican population

    AJ. Hernández-Medrano, DP. Romero-Terán, MA. Ruiz-Mafud, MAG. Medrano-Delgado, MF. Medina-Pérez, AY. Regalado-Mustafá, DR. Aguila-Godinez, LG. Lira-Juarez, A. Domínguez-García, G. Hernández-Armesto, EC. Santiago-Delacruz, AA. Herrera-Ruiz, K. Talavera Lagunas, GI. Cerda-Hernández, A. Alcocer-Salas, JF. García-Hernández, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (La Fama, Tlalpan, Mexico)

  • Gender-Specific Classification Models for Parkinson’s Disease using Non-Motor Symptoms and DNA Methylation Data

    MZA. Ali, PSD. Dholaniya (Hyderabad, India)

  • Gender-specific differences of gait in parkinsonian syndromes

    V. Sidoroff, F. Jagusch, P. Bachmann, N. Roth, N. Hergenröder-Lenzner, I. Teckenburg, A. Ibrahim, S. Büchner, D. Benninger, K. Seppi, F. Krismer, B. Eskofier, J. Winkler, J. Klucken, K. Aminian, H. Gassner, G. Wenning, C. Raccagni (Innsbruck, Austria)

  • Gene rearrangement as the cause of hereditary Hypomyelinating Leukodyistrophy disease type 5 (HLD5)

    A. Menéndez-Albarracín, P. Pastor-Muñoz, K. Beyer, M. Gea-Rispal, D. Vilas-Roldán, R. Alvarez-Ramo, L. Ispierto-González (Barcelona, Spain)

  • Gene-environment interactions for Parkinson’s disease

    R. Torricelli, A. Reynoso, B. Jacobs, J. Shi, S. Aslibekyan, L. Kaufmann, A. Noyce, K. Heilbron (London, United Kingdom)

  • Generalized acute myoclonus caused by chikungunya virus encephalitis: case report.

    A. Gomes, A. Marinho, F. Rolim, D. Lima, F. Araújo, K. Menezes, V. Mesquita, F. Maia Carvalho (Fortaleza, Brazil)

  • Generalized chorea, cerebellar ataxia and spastic tetraparesis with a genetic mutation in FAT2 gene – coincidence or a new SCA45 phenotype?

    M. Sequeira, D. Melancia (Lisboa, Portugal)

  • Generalized dystonia and spasticity: The fault in the mitochondria

    A. Saini, S. Khanna (Chandigarh, India)

  • Genetic and functional analysis of CCDC88C mutations in patients with Parkinson’s disease.

    S. Chen, J. Chen, X. Xie, W. Luo (Hangzhou, China)

  • Genetic and phenotypic characterization of ATX-FAT2 (SCA45) in three Indian families

    J. Ganguly, P. Basu, B. Mondal, H. Kumar (Kolkata, India)

  • Genetic and psychiatric risk factors for impulse control disorders in de novo Parkinson’s disease

    M. Ruitenberg, E. Whooley, H. Macdonald, V. Koppelmans (Leiden, Netherlands)

  • Genetic diagnosis of parkinsonian phenotype of Machado Joseph Diseasep (SCA-3) presenting with dopa induced dyskinesia

    D. Chaudhari, A. Mishra, P. Renjen, K. Ahmad, N. Sahu (New Delhi, India)

  • Genetic outcomes of South Asian Parkinsonism cohort: from a tertiary care hospital

    P. Paramanandam, A. S, A. Deenadayalu, I. N, K. Gowrishankar, T. Koshy (Chennai, India)

  • Genetic polymorphisms associated with nigrostriatal dopaminergic depletion as measured with [I123]-FP-CIT SPECT in Parkinson’s disease

    S. Castro Labrador, MA. Labrador Espinosa, J. Silva Rodríguez, D. García Solís, P. Mir, MJ. Grothe (Seville, Spain)

  • Genetic profile of early-onset Parkinson’s Disease patients at a movement disorders center in Brazil

    M. Costa, A. Pessoa-Neto, F. Sarmento, G. Lima, C. Silva, L. Barcelos, P. Aguiar, S. Azevedo, V. Borges, H. Ferraz (São Paulo, Brazil)

  • Genetic spectrum of monogenic dystonia in Asian Indian patients

    R. Rajan, A. Saini, R. Mewara, B. Verma, D. Radhakrishnan, A. Agarwal, E. A, A. Gupta, V. V Y, M. Singh, R. Bhatia, I. Singh, R. Mir, F. Mohammad, B. B K, V. Scaria, A. Srivastava, M V. Srivastava (New Delhi, India)

  • Genetic study of early-onset Parkinson’s disease in the Malaysian population

    YW. Tay, AH. Tan, JL. Lim, K. Lohmann, K. Azmi Ibrahim, Z. Abdul Aziz, YT. Chin, AS. Mawardi, TT. Lim, I. Looi, YK. Chia, JCE. Ooi, WK. Cheah, A. Dy Closas, LC. Lit, JW. Hor, TS. Toh, K. Muthusamy, P. Bauer, V. Skrahin, A. Rolfs, C. Klein, A. Ahmad-Annuar, SY. Lim (Kuala Lumpur, Malaysia)

  • Genetic subtypes of Parkinson’s disease in a Colorado clinic

    M. Lafreniere, G. Bosma, E. Forbes (Aurora, USA)

  • Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease

    G. Chevalier, L. Udovin, M. Otero-Losada, S. Bordet, F. Capani, S. Luo, C. Goetz, S. Perez-Lloret (Buenos Aires, Argentina)

  • Genetics of Parkinson’s Disease in Polish patients with positive family history-preeliminary study.

    L. Milanowski, D. Hoffman-Zacharska, M. Geremek, S. Szlufik, A. Friedman, D. Koziorowski (Warsaw, Poland)

  • Genome Wide Association Studies using TRACTOR reveals new associated loci with Parkinson Disease in a Latino Cohort

    T. Leal, V. Borda, M. Gouveia, M. Inca-Martinez, E. Mason, D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Olivas, L. Torres, P. Mazzetti, C. Cosentino, E. Sarapura-Castro, A. Rivera-Valdivia, A. Medina, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, S. Moreno, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O'Connor, I. Mata (Cleveland, USA)

  • Genome-wide association identifies novel etiological insights associated with Parkinson’s Disease in African and African admixed populations

    M. Rizig, S. Bandres Ciga, M. Makarious, O. Ojo, O. Okunoye, K. Levine, E. Sidransky, N. Tayebi, P. Wild Crea, C. Blauwendraat, H. Houlden, J. Hardy, A. Singleton, N. Okubadejo (London, United Kingdom)

  • Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism

    R. Matmurodov, E. Abduqodirov, R. Juraev, O. Naimov, B. Muminov, K. Khalimova, H. Daminova (Tashkent, Uzbekistan)

  • Globus pallidus interna deep brain stimulation for Parkinson’s Disease: Impact on Restless Legs Syndrome

    A. Wiltshire, A. Mahes, S. Wang, R. Zuzuárregui (San Francisco, USA)

  • Glucocerebrosidase (GCase) activator, Ambroxol, reduces alpha-synuclein serine-129 phosphorylation and oligomers in mutant LRRK2 R1441G mouse brains

    Z. Choi, E. Chang, H. Liu, S. Zhang, Y. Ruan, K. Leung, S. Pang, M. Kung, D. Ramsden, S. Ho, P. Ho (Hong Kong, Hong Kong)

  • Glunomab: a novel therapeutics for the treatment of Parkinson’s Disease

    D. Torrente, E. Su, GP. Schielke, M. Warnock, T. Stevenson, K. Mann, F. Lesept, N. Delétage, M. Blanc, D. Vivien, D. Lawrence (Ann Arbor, USA)

  • Gluten-free diet in Parkinson’s disease patients – feasibility, safety and preliminary results

    H. Brozova, K. Polakova, M. Fialova, T. Gentileova, J. Rusz, D. Funda (Prague, Czech Republic)

  • Glycated alpha-synuclein and it emerging role in early onset of Parkinson’s disease

    S. Chatterjee, H. Thakkar, A. Khairnar, R. Shah (Gandhinagar, India)

  • Gray matter volume changes in occipital and temporal visual brain region are associated with freezing of gait in Parkinson’s

    YX. Li, ZL. Luo, XL. Yang (Kunming, China)

  • GT-02287, a brain-penetrant structurally targeted allosteric regulator for glucocerebrosidase shows evidence of pharmacological efficacy in an animal model of Parkinson’s disease.

    B. Calvo-Flores Guzman, N. Perez-Carmona, A. Garcia-Collazo, E. Cubero, X. Barril, M. Bellotto, J. Taylor (Lugano, Switzerland)

  • Gut dysbiosis in Indian Parkinson’s Disease Patients with Constipation

    S. Pavan, M. Ballal, A. Prabhu, B. Das, A. Mutreja, K. Vasudevan (Manipal, India)

  • Gut microbiota dysbiosis in Parkinson’s disease patients: a potential biomarker of disease severity and progression?

    R. Cerroni, M. Conti, M. Pierantozzi, V. D'Angelo, N. Mercuri, A. Teofani, D. Pietrucci, G. Chillemi, V. Unida, A. Stefani (Rome, Italy)

Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley